Security
ZAI LAB LTD SHS NEW US$0.000006 (Cayman Islands) · ZAILF
ZAILFOTCCommon stockCurrentCIK 1704292Updated Oct 26, 2026
Name history
Zai Lab Ltd · through Oct 23, 2026
ZAILF price & chart
Loading TradingView…
OTC:ZAILF on TradingView ↗About the company
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) is an innovative, research-based, commercial-stage biopharmaceutical company based in China and the United States. We are focused on discovering, developing, and commercializing innovative products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. Our goal is to leverage our competencies and resources to positively impact human health.
In the news
No coverage from other publishers is available.
Recent filings
Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities · Regulation FD Disclosure · Other Events
Items 1.01, 3.02, 7.01, 8.01, 9.01
4 filing
144 filing
4 filing
4 filing
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 1,158,940,000Source | 985,346,000Source | 1,074,793,000Source | 1,164,101,000Source | 987,368,000Source | 1,095,737,000Source | 1,173,330,000Source | 988,437,000Source | 1,172,384,000Source | 1,185,753,000Source | 1,036,295,000Source | 1,220,140,000Source |
| Property, Plant and Equipment, NetUSD | 48,868,000Source | 50,765,000Source | 46,431,000Source | 50,160,000Source | 50,613,000Source | 47,067,000Source | 49,654,000Source | 52,386,000Source | 47,389,000Source | 47,961,000Source | 53,734,000Source | 57,863,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 55,278,000Source | 51,669,000Source | 85,774,000Source | 56,519,000Source | 44,063,000Source | 75,759,000Source | 56,198,000Source | 12,398,000Source | 76,144,000Source | 56,027,000Source | 13,389,000Source | 1,511,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 717,155,000Source | 616,086,000Source | 607,522,000Source | 732,159,000Source | 630,048,000Source | 651,316,000Source | 757,263,000Source | 650,780,000Source | 679,573,000Source | 449,667,000Source | 790,151,000Source | 1,008,470,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 85,377,000Source | 49,970,000Source | 69,595,000Source | 88,499,000Source | 69,635,000Source | 54,069,000Source | 76,555,000Source | 60,422,000Source | 106,116,000Source | 85,178,000Source | 59,199,000Source | 39,963,000Source |
| Inventory, NetUSD | 67,135,000Source | 39,548,000Source | 90,890,000Source | 61,700,000Source | 41,846,000Source | 85,961,000Source | 53,054,000Source | 37,851,000Source | 74,745,000Source | 39,875,000Source | 44,827,000Source | 31,621,000Source |
| Assets, CurrentUSD | 1,032,948,000Source | 860,549,000Source | 914,037,000Source | 1,034,062,000Source | 869,923,000Source | 944,729,000Source | 1,041,868,000Source | 888,640,000Source | 1,019,286,000Source | 1,050,480,000Source | 939,606,000Source | 1,124,336,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 43,653,000Source | 35,667,000Source | 32,635,000Source | 40,750,000Source | 20,292,000Source | 35,454,000Source | 43,878,000Source | 24,224,000Source | 36,683,000Source | 41,527,000Source | 22,995,000Source | 35,674,000Source |
| Operating Lease, Right-of-Use AssetUSD | 15,751,000Source | 12,833,000Source | 16,159,000Source | 16,787,000Source | 13,102,000Source | 17,585,000Source | 19,081,000Source | 15,187,000Source | 19,152,000Source | 21,496,000Source | 14,844,000Source | 19,512,000Source |
| Other Assets, NoncurrentUSD | 2,128,000Source | — | 3,543,000Source | 2,599,000Source | — | 3,168,000Source | 2,534,000Source | — | 3,054,000Source | — | — | — |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 398,995,000Source | 317,677,000Source | 467,756,000Source | 372,366,000Source | 283,189,000Source | 433,756,000Source | 362,577,000Source | 226,268,000Source | 456,884,000Source | 344,855,000Source | 240,177,000Source | 174,545,000Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 7,000Source | 6,000Source | 7,000Source | 7,000Source | 6,000Source | 7,000Source | 7,000Source | 6,000Source | 7,000Source | 7,000Source | 6,000Source | 6,000Source |
| Retained Earnings (Accumulated Deficit)USD | -2,578,211,000Source | -2,371,399,000Source | -2,730,461,000Source | -2,542,248,000Source | -2,329,728,000Source | -2,679,636,000Source | -2,501,521,000Source | -2,249,451,000Source | -2,628,620,000Source | -2,453,083,000Source | -2,195,980,000Source | -1,861,360,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 39,645,000Source | 28,270,000Source | 214,000Source | 46,348,000Source | 42,773,000Source | 15,105,000Source | 49,303,000Source | 39,168,000Source | 29,697,000Source | 50,515,000Source | 37,626,000Source | 25,685,000Source |
| Stockholders' Equity Attributable to ParentUSD | 759,945,000Source | 667,669,000Source | 607,037,000Source | 791,735,000Source | 704,179,000Source | 661,981,000Source | 810,753,000Source | 762,169,000Source | 715,500,000Source | 840,898,000Source | 796,118,000Source | 1,045,595,000Source |
| Additional Paid in Capital, Common StockUSD | 3,327,557,000Source | 3,031,628,000Source | 3,370,798,000Source | 3,308,491,000Source | 3,011,964,000Source | 3,357,826,000Source | 3,283,800,000Source | 2,993,282,000Source | 3,343,469,000Source | 3,264,295,000Source | 2,975,302,000Source | 2,893,120,000Source |
| Liabilities and EquityUSD | 1,158,940,000Source | 985,346,000Source | 1,074,793,000Source | 1,164,101,000Source | 987,368,000Source | 1,095,737,000Source | 1,173,330,000Source | 988,437,000Source | 1,172,384,000Source | 1,185,753,000Source | 1,036,295,000Source | 1,220,140,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 359,769,000Source | 286,315,000Source | 428,584,000Source | 331,501,000Source | 251,718,000Source | 392,982,000Source | 319,807,000Source | 192,106,000Source | 416,166,000Source | 299,385,000Source | 203,067,000Source | 139,842,000Source |
| Operating Lease, Liability, CurrentUSD | 5,496,000Source | 6,585,000Source | 5,025,000Source | 5,584,000Source | 7,581,000Source | 5,983,000Source | 6,574,000Source | 7,536,000Source | 6,344,000Source | 8,048,000Source | 7,104,000Source | 7,050,000Source |
| Accounts Payable, CurrentUSD | 99,706,000Source | 120,652,000Source | 136,692,000Source | 107,357,000Source | 127,344,000Source | 126,169,000Source | 103,017,000Source | 88,121,000Source | 141,608,000Source | 100,906,000Source | 112,991,000Source | 65,974,000Source |
| Operating Lease, Liability, NoncurrentUSD | 10,840,000Source | 6,113,000Source | 11,447,000Source | 11,307,000Source | 5,803,000Source | 12,107,000Source | 12,319,000Source | 7,540,000Source | 13,385,000Source | 13,712,000Source | 8,047,000Source | 13,343,000Source |
| Other Liabilities, NoncurrentUSD | 325,000Source | 325,000Source | 225,000Source | 325,000Source | 325,000Source | 40,000Source | 325,000Source | 325,000Source | 0Source | 325,000Source | 325,000Source | — |
| Additional Financial Items | ||||||||||||
| Short-term InvestmentsUSD | 0Source | 0Source | 10,000,000Source | 0Source | 0Source | 10,000,000Source | 0Source | 0Source | 10,000,000Source | 330,000,000Source | 16,300,000Source | 0Source |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | 3,944,000Source | 3,458,000Source | 15,010,000Source | 11,856,000Source | 9,029,000Source | 8,227,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 13,524,000Source | 15,800,000Source | 65,598,000Source | 70,651,000Source | 79,634,000Source | 61,302,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | -53,268,000Source | -8,737,000Source | 18,932,000Source | 26,975,000Source | 20,040,000Source | -4,330,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | 11,208,000Source | 13,198,000Source | 47,028,000Source | -3,896,000Source | 14,907,000Source | 15,382,000Source |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | 4,261,000Source | 2,720,000Source | 19,926,000Source | -2,209,000Source | 36,803,000Source | -53,773,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -11,912,000Source | -61,699,000Source | -150,789,000Source | -214,869,000Source | -198,178,000Source | -367,642,000Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -22,288,000Source | 326,133,000Source | 307,866,000Source | -375,193,000Source | -10,776,000Source | 420,016,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 1,195,000Source | 1,534,000Source | 8,101,000Source | 5,657,000Source | 7,212,000Source | 24,585,000Source |
| Cash flows from financing activities: | ||||||||||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | — | — | — | — | — | — | 2,270,000Source | 0Source | 8,218,000Source | 0Source | 8,802,000Source | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 5,573,000Source | 43,141,000Source | 72,353,000Source | 349,889,000Source | -6,433,000Source | -1,730,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -28,256,000Source | 307,595,000Source | 229,908,000Source | -240,483,000Source | -218,009,000Source | 44,370,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | 1,399,000Source | 1,101,000Source | 4,878,000Source | 2,021,000Source | — | 0Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 16,923,000Source | 16,795,000Source | 12,126,000Source | 16,973,000Source | 13,564,000Source | 15,800,000Source | 65,598,000Source | 70,651,000Source | 79,634,000Source | 61,302,000Source |
| Amortization of Debt Issuance CostsUSD | — | — | — | — | — | — | — | 0Source | 194,000Source | 700,000Source | — | — |
| Amortization of Intangible AssetsUSD | — | — | 1,500,000Source | 700,000Source | 1,800,000Source | 1,500,000Source | 1,600,000Source | 1,500,000Source | 5,900,000Source | 3,200,000Source | 700,000Source | 500,000Source |
| DepreciationUSD | — | — | 2,400,000Source | 2,100,000Source | 2,400,000Source | 2,300,000Source | 2,300,000Source | 2,000,000Source | 9,100,000Source | 8,600,000Source | 8,400,000Source | 7,700,000Source |
| Equity Securities, FV-NI, Gain (Loss)USD | — | — | 0Source | -920,000Source | — | — | 0Source | -1,912,000Source | -1,912,000Source | -6,105,000Source | 2,789,000Source | -8,952,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | 6,422,000Source | 14,457,000Source | 15,065,000Source | 2,837,000Source | 14,837,000Source | 651,000Source | 19,591,000Source | -15,137,000Source | -14,850,000Source | -56,403,000Source |
| Foreign Currency Transaction Gain (Loss), UnrealizedUSD | — | — | — | — | — | — | 14,837,000Source | 651,000Source | 19,591,000Source | -15,137,000Source | -14,850,000Source | -56,403,000Source |
| Gain (Loss) on Disposition of Intangible AssetsUSD | — | — | — | 0Source | — | — | — | — | 0Source | 0Source | 10,000,000Source | — |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | — | — | — | — | — | -18,000Source | 0Source | -542,000Source | -453,000Source | -159,000Source | -560,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | — | — | — | — | — | — | — | — | — | 0Source | 0Source | -221,000Source |
| Income Tax Expense (Benefit)USD | — | — | 0Source | 0Source | -1,022,000Source | 0Source | 1,440,000Source | 0Source | -2,927,000Source | 0Source | 0Source | 0Source |
| InterestExpenseNonoperatingUSD | — | — | 1,400,000Source | 745,000Source | 1,587,000Source | 1,262,000Source | 1,637,000Source | 1,187,000Source | 5,209,000Source | — | — | — |
| Inventory Write-downUSD | — | — | — | — | — | — | 188,000Source | 27,000Source | 12,288,000Source | 815,000Source | 973,000Source | 477,000Source |
| Investment Income, InterestUSD | — | — | 8,345,000Source | 9,029,000Source | 5,879,000Source | 8,843,000Source | 6,447,000Source | 8,606,000Source | 33,048,000Source | 37,105,000Source | 39,797,000Source | 14,582,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -35,963,000Source | -41,671,000Source | -50,825,000Source | -40,727,000Source | -51,016,000Source | -48,438,000Source | -175,537,000Source | -257,103,000Source | -334,620,000Source | -443,286,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | — | — | — | — | — | -175,537,000Source | -257,103,000Source | -334,620,000Source | -443,286,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -508,000Source | 3,441,000Source | 5,285,000Source | 3,750,000Source | 162,000Source | -197,000Source | 3,540,000Source | 5,300,000Source | 7,006,000Source | 3,113,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | — | — | 0Source | 217,350,000Source | — | — |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | 833,000Source | 3,009,000Source | 13,675,000Source | 3,200,000Source | 2,369,000Source | 5,870,000Source |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 115,361,000Source | 101,847,000Source | 105,751,000Source | 109,085,000Source | 95,556,000Source | 105,650,000Source | 457,182,000Source | 397,614,000Source | 266,719,000Source | 212,672,000Source |
| Cost of RevenueUSD | — | — | 46,764,000Source | 36,569,000Source | 48,162,000Source | 43,003,000Source | 38,315,000Source | 38,452,000Source | 190,520,000Source | 147,118,000Source | 95,816,000Source | 74,018,000Source |
| Gross Profit (Calculated) · Derived | — | — | — | — | — | — | — | — | — | — | — | — |
| Selling, General and Administrative ExpenseUSD | — | — | 70,106,000Source | 67,219,000Source | 72,872,000Source | 71,038,000Source | 65,070,000Source | 63,422,000Source | 277,605,000Source | 298,741,000Source | 281,608,000Source | 258,971,000Source |
| Operating Income (Loss)USD | — | — | -48,822,000Source | -67,853,000Source | -76,489,000Source | -54,895,000Source | -69,385,000Source | -56,311,000Source | -229,434,000Source | -282,117,000Source | -366,573,000Source | -404,357,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -508,000Source | 3,441,000Source | 5,285,000Source | 3,750,000Source | 162,000Source | -197,000Source | 3,540,000Source | 5,300,000Source | 7,006,000Source | 3,113,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -35,963,000Source | -41,671,000Source | -51,847,000Source | -40,727,000Source | -49,576,000Source | -48,438,000Source | -178,464,000Source | -257,103,000Source | -334,620,000Source | -443,286,000Source |
| Income Tax Expense (Benefit)USD | — | — | 0Source | 0Source | -1,022,000Source | 0Source | 1,440,000Source | 0Source | -2,927,000Source | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -35,963,000Source | -41,671,000Source | -50,825,000Source | -40,727,000Source | -51,016,000Source | -48,438,000Source | -175,537,000Source | -257,103,000Source | -334,620,000Source | -443,286,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.03Source | -0.04Source | -0.05Source | -0.04Source | -0.05Source | -0.04Source | -0.16Source | -0.26Source | -0.35Source | -0.46Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.03Source | -0.04Source | -0.05Source | -0.04Source | -0.05Source | -0.04Source | -0.16Source | -0.26Source | -0.35Source | -0.46Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 1,102,072,680Source | 981,687,390Source | 1,116,973,380Source | 1,091,933,150Source | 1,107,390,590Source | 1,080,825,300Source | 1,095,311,090Source | 989,477,730Source | 966,394,130Source | 958,067,140Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 1,102,072,680Source | 981,687,390Source | 1,116,973,380Source | 1,091,933,150Source | 1,107,390,590Source | 1,080,825,300Source | 1,095,311,090Source | 989,477,730Source | 966,394,130Source | 958,067,140Source |
| Interest Expense (non-operating)USD | — | — | 1,400,000Source | 745,000Source | 1,587,000Source | 1,262,000Source | 1,637,000Source | 1,187,000Source | 5,209,000Source | — | — | — |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | 1,500,000Source | 700,000Source | 1,800,000Source | 1,500,000Source | 1,600,000Source | 1,500,000Source | 5,900,000Source | 3,200,000Source | 700,000Source | 500,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | 6,422,000Source | 14,457,000Source | 15,065,000Source | 2,837,000Source | 14,837,000Source | 651,000Source | 19,591,000Source | -15,137,000Source | -14,850,000Source | -56,403,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | — | — | — | — | — | — | — | — | — | 0Source | 0Source | -221,000Source |
| Interest ExpenseUSD | — | — | — | — | — | — | — | — | — | 2,254,000Source | — | 0Source |
| Investment Income, InterestUSD | — | — | 8,345,000Source | 9,029,000Source | 5,879,000Source | 8,843,000Source | 6,447,000Source | 8,606,000Source | 33,048,000Source | 37,105,000Source | 39,797,000Source | 14,582,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | — | — | — | — | — | -175,537,000Source | -257,103,000Source | -334,620,000Source | -443,286,000Source |
| Other Cost of Operating RevenueUSD | — | — | 119,000Source | 348,000Source | 0Source | 217,000Source | 20,000Source | 195,000Source | 561,000Source | 742,000Source | — | — |
| Research and Development ExpenseUSD | — | — | 47,928,000Source | 65,982,000Source | 61,766,000Source | 50,614,000Source | 65,591,000Source | 60,729,000Source | 220,904,000Source | 234,504,000Source | 265,868,000Source | 286,408,000Source |
Filing attachments
zlab-202686x8kex991.htm · 8-K · 2026-08-06
EX-99.1 2 zlab-202686x8kex991.htm EX-99.1 Document Exhibit 99.1 Zai Lab Announces Second Quarter 2026 Financial Results and Recent Corporate Updates - The Company advanced multiple global oncology and immunology programs toward key clinical and regulatory milestones, with significant pipeline catalysts expected in the second half of 2026 - Global Phase 1 data for zocilurtatug pelitecan (zoci) in combination with a PD-L1 inhibitor in first-line SCLC to be presented at ESMO 2026; planned …
Read attachment ↗zlab-202657x8kex991.htm · 8-K · 2026-05-07
EX-99.1 2 zlab-202657x8kex991.htm EX-99.1 Document Exhibit 99.1 Zai Lab Announces First Quarter 2026 Financial Results and Recent Corporate Updates - Total revenues of $99.6 million for the first quarter of 2026, reflecting anticipated first-quarter dynamics, including certain competitive impacts for ZEJULA and pricing adjustment related to NRDL renewal for VYVGART - Zocilurtatug pelitecan (zoci) delivered standout data at AACR 2026, with a 62.5% confirmed intracranial ORR in SCLC patie…
Read attachment ↗